CCL2/CCR4 participates in mast cell-mediated epithelial mesenchymal transition in endometriosis

Ding S, Shaojie Ding, Mao X, Xinqi Mao, Zhu L, Libo Zhu, Xu X, Xinxin Xu, Chen S, Shuyi Chen, Zou G, Gen Zou, Xu P, Ping Xu, Jianzhang Wang, Wang J, Xinmei Zhang
Reproductive biomedicine online · 2025 · vol. 51(2) , pp. 104796 · doi:10.1016/j.rbmo.2025.104796 · PMID:40472665 · W4406579965
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigates the role of CCL2/CCR4 signaling in mast cell-mediated epithelial mesenchymal transition, a process implicated in endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

RESEARCH QUESTION: Do mast cells play a role in the pathogenesis of endometriosis and, if so, what is the mechanism of action? DESIGN: The study included 18 women with ovarian endometriosis and 13 women without endometriosis. Primary endometrial epithelial cells (EPC) were isolated and purified, and co-cultured with human mast cell line HMC-1.1 to explore the role and mechanisms of mast cells on epithelial mesenchymal transition (EMT) in EPC in vitro. Then, wild/c-kitsh mouse model of endometriosis was established by abdominal allogeneic endometrial transplantation in vivo. The number and location of mast cells in human/mouse endometrial tissue were determined by immunofluorescence staining. The expression levels of molecules related to CCL2, CCR4 and EMT were measured by quantitative reverse transcription polymerase chain reaction, Western blot and immunohistochemical staining analysis, respectively. RESULTS: The number of infiltrated activated mast cells was positively correlated with EMT in human endometriotic lesions (CDH2, r = 0.53, P = 0.002; CDH1, r = -0.72, P < 0.001). Subsequently, mast cells promoted the migration and EMT of EPC through Mas-related G-protein-coupled receptor X2 (MRGPRX2)/C-C motif chemokine ligand 2 (CCL2)/C-C chemokine receptor 4 (CCR4) signalling pathway in vitro. Finally, wild/c-kitsh mouse model of endometriosis showed that deficiency of mast cell activation suppressed the development of endometriosis via the restriction of EMT. CONCLUSION: Mast cells are involved in the pathogenesis of endometriosis via MRGPRX2/CCL2/CCR4/EMT signals, thus providing a potential novel therapeutic approach for the treatment of endometriosis by targeting MRGPRX2/CCL2/CCR4 pathway.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2 Chemokine CCL2

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (64)

Cited by (1)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-28T06:10:17.885159+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK